Cancer trial discovers a potentially broader role for an established dual HER2-blocking treatment
An important discovery from the NCI-MATCH precision medicine initiative is published in Clinical Cancer Research.
Mar 4, 2024
0
5
An important discovery from the NCI-MATCH precision medicine initiative is published in Clinical Cancer Research.
Mar 4, 2024
0
5
Soy compounds called isoflavones are among the plant-derived compounds that may significantly reduce the risk of breast cancer recurrence or death, according to a new meta-analysis co-directed by investigators from the Johns ...
Jan 10, 2024
0
1
With tens of thousands of synthetic chemicals on the market, and new ones in development all the time, knowing which ones might be harmful is a challenge both for the federal agencies that regulate them and the companies ...
Jan 10, 2024
2
60
Thirty years ago, Gail Sonenshein was studying cancer in immune cells when she read an article in the New York Times that would shape the rest of her career. The article described a new residency program in women's health, ...
Jan 9, 2024
0
0
A study conducted by Professor Jiyoung Park and her research team in the Department of Biological Sciences at UNIST has identified FAM3C, a metabolism-regulating signaling molecule produced by cancer-associated adipocytes ...
Jan 8, 2024
0
0
A large international team of doctors and medical researchers has found evidence that suggests people who stop consuming alcoholic beverages can reduce their risk of developing some types of cancers. In their study, reported ...
For patients with early-stage breast cancer, there is a 7% to 11% chance of relapse within five years after receiving initial treatment, and this rate can be higher for patients with more advanced stages of the cancer. While ...
Dec 29, 2023
0
67
Immunotherapy in combination with chemotherapy has become an important therapeutic treatment option in some patients with metastatic breast cancer. Which patients will benefit the most, however, remains unclear; current biomarkers ...
Dec 14, 2023
0
0
A new review paper titled "Risk factors for long-term arm morbidities following breast cancer treatments: A systematic review" has been published in Oncotarget.
Dec 11, 2023
0
0
The largest review of papers for brain cancer that has spread from the lungs has found abnormalities in the brain cancer for which licensed drugs could be clinically trialed to find out if they could treat the disease. The ...
Nov 29, 2023
0
0